IS4791A - 2-Amínó-5,6-díklóróbenzimídazól afleiður með virkni gegn veirum - Google Patents
2-Amínó-5,6-díklóróbenzimídazól afleiður með virkni gegn veirumInfo
- Publication number
- IS4791A IS4791A IS4791A IS4791A IS4791A IS 4791 A IS4791 A IS 4791A IS 4791 A IS4791 A IS 4791A IS 4791 A IS4791 A IS 4791A IS 4791 A IS4791 A IS 4791A
- Authority
- IS
- Iceland
- Prior art keywords
- dichlorobenzimidazole
- derivatives
- amino
- antiviral activity
- antiviral
- Prior art date
Links
- HAADRTMPUSJNOI-UHFFFAOYSA-N 5,6-dichloro-1h-benzimidazol-2-amine Chemical class ClC1=C(Cl)C=C2NC(N)=NC2=C1 HAADRTMPUSJNOI-UHFFFAOYSA-N 0.000 title 1
- 230000000840 anti-viral effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9600142.5A GB9600142D0 (en) | 1996-01-05 | 1996-01-05 | Chemical compounds |
| PCT/EP1997/000018 WO1997025316A1 (en) | 1996-01-05 | 1997-01-03 | 2-amino-5,6-dichlorobenzimidazole derivatives having antiviral activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4791A true IS4791A (is) | 1998-06-30 |
Family
ID=10786609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4791A IS4791A (is) | 1996-01-05 | 1998-06-30 | 2-Amínó-5,6-díklóróbenzimídazól afleiður með virkni gegn veirum |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5998398A (is) |
| EP (1) | EP0886635A1 (is) |
| JP (1) | JP2000503017A (is) |
| KR (1) | KR19990077040A (is) |
| CN (1) | CN1212683A (is) |
| AP (1) | AP9801287A0 (is) |
| AU (1) | AU1438997A (is) |
| BR (1) | BR9706938A (is) |
| CA (1) | CA2241893A1 (is) |
| CZ (1) | CZ212798A3 (is) |
| EA (1) | EA199800527A1 (is) |
| GB (1) | GB9600142D0 (is) |
| HU (1) | HUP9900580A3 (is) |
| IS (1) | IS4791A (is) |
| NO (1) | NO983089L (is) |
| OA (1) | OA10706A (is) |
| PL (1) | PL327686A1 (is) |
| TR (1) | TR199801290T2 (is) |
| WO (1) | WO1997025316A1 (is) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6872742B2 (en) | 1996-08-28 | 2005-03-29 | The Procter & Gamble Company | Substituted cyclic amine metalloprotease inhibitors |
| EP0970100B1 (en) | 1997-02-13 | 2003-11-12 | Glaxo Group Limited | Benzimidazole derivatives |
| US6455506B1 (en) | 1997-07-30 | 2002-09-24 | Smithkline Beecham Corporation | Lyxofuranosyl benzimidazoles as antiviral agents |
| CA2363274A1 (en) * | 1999-12-27 | 2001-07-05 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs for hepatitis c |
| US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
| GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
| AR035543A1 (es) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
| ES2367422T3 (es) | 2001-10-09 | 2011-11-03 | Amgen Inc. | Derivados de imidazol como agentes antiinflamatorios. |
| WO2005012288A1 (en) | 2003-08-01 | 2005-02-10 | Genelabs Technologies, Inc | Bicyclic imidazol derivatives against flaviviridae |
| EP1863771B1 (en) * | 2005-03-14 | 2012-11-07 | High Point Pharmaceuticals, LLC | Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| GB201223265D0 (en) | 2012-12-21 | 2013-02-06 | Selvita Sa | Novel benzimidazole derivatives as kinase inhibitors |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4492708A (en) * | 1982-09-27 | 1985-01-08 | Eli Lilly And Company | Antiviral benzimidazoles |
| US4996308A (en) * | 1988-03-25 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group |
| ZA894534B (en) * | 1988-06-20 | 1990-03-28 | Merrell Dow Pharma | Novel neplanocin derivatives |
| GB8826205D0 (en) * | 1988-11-09 | 1988-12-14 | Wellcome Found | Heterocyclic compounds |
| GB8926417D0 (en) * | 1989-11-22 | 1990-01-10 | Wellcome Found | Heterocyclic compounds |
| MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
| JPH03223264A (ja) * | 1990-01-30 | 1991-10-02 | Nippon Kayaku Co Ltd | 新規なシクロペンタン誘導体及びその製造法 |
| US5248672A (en) * | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
| EP0521463A3 (en) * | 1991-07-04 | 1993-04-14 | Hoechst Aktiengesellschaft | Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents |
| JPH05141464A (ja) * | 1991-11-15 | 1993-06-08 | Kajima Corp | 積層ゴム支承及び該積層ゴム支承を用いた構造物の振動制御装置 |
| GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
| WO1994008456A1 (en) * | 1992-10-21 | 1994-04-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazoles as antiviral agents |
| US5399580A (en) * | 1993-03-08 | 1995-03-21 | Burroughs Wellcome Co. | Therapeutic nucleosides-uses |
| GB9413724D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
| AU3692895A (en) * | 1994-09-09 | 1996-03-27 | Regents Of The University Of Michigan, The | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
-
1996
- 1996-01-05 GB GBGB9600142.5A patent/GB9600142D0/en active Pending
-
1997
- 1997-01-03 US US09/101,101 patent/US5998398A/en not_active Expired - Fee Related
- 1997-01-03 HU HU9900580A patent/HUP9900580A3/hu unknown
- 1997-01-03 CZ CZ982127A patent/CZ212798A3/cs unknown
- 1997-01-03 EA EA199800527A patent/EA199800527A1/ru unknown
- 1997-01-03 BR BR9706938A patent/BR9706938A/pt not_active Application Discontinuation
- 1997-01-03 EP EP97900953A patent/EP0886635A1/en not_active Withdrawn
- 1997-01-03 CA CA002241893A patent/CA2241893A1/en not_active Abandoned
- 1997-01-03 CN CN97192658A patent/CN1212683A/zh active Pending
- 1997-01-03 KR KR1019980705173A patent/KR19990077040A/ko not_active Withdrawn
- 1997-01-03 WO PCT/EP1997/000018 patent/WO1997025316A1/en not_active Application Discontinuation
- 1997-01-03 AU AU14389/97A patent/AU1438997A/en not_active Abandoned
- 1997-01-03 TR TR1998/01290T patent/TR199801290T2/xx unknown
- 1997-01-03 JP JP9524843A patent/JP2000503017A/ja active Pending
- 1997-01-03 PL PL97327686A patent/PL327686A1/xx unknown
- 1997-01-03 AP APAP/P/1998/001287A patent/AP9801287A0/en unknown
-
1998
- 1998-06-30 IS IS4791A patent/IS4791A/is unknown
- 1998-06-30 OA OA9800097A patent/OA10706A/en unknown
- 1998-07-03 NO NO983089A patent/NO983089L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990077040A (ko) | 1999-10-25 |
| AU1438997A (en) | 1997-08-01 |
| CA2241893A1 (en) | 1997-07-17 |
| TR199801290T2 (xx) | 1998-09-21 |
| US5998398A (en) | 1999-12-07 |
| PL327686A1 (en) | 1998-12-21 |
| HUP9900580A3 (en) | 2000-01-28 |
| EA199800527A1 (ru) | 1999-02-25 |
| NO983089D0 (no) | 1998-07-03 |
| AP9801287A0 (en) | 1998-09-30 |
| GB9600142D0 (en) | 1996-03-06 |
| WO1997025316A1 (en) | 1997-07-17 |
| NO983089L (no) | 1998-09-01 |
| OA10706A (en) | 2001-05-08 |
| JP2000503017A (ja) | 2000-03-14 |
| HUP9900580A2 (hu) | 1999-06-28 |
| CZ212798A3 (cs) | 1998-12-16 |
| CN1212683A (zh) | 1999-03-31 |
| EP0886635A1 (en) | 1998-12-30 |
| BR9706938A (pt) | 1999-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004787L (no) | Indolderivater med antiviral aktivitet | |
| DE122005000003I1 (de) | Heterocyclische Azahexanderivate mit Antiviraler wirkung. | |
| FI953523L (fi) | Fenyyli-3-dimetyyliamino-propaaniyhdisteet, joilla on farmakologista vaikutusta | |
| IS5635A (is) | Indólýl-3-glýoxýlsýru afleiður með virkni gegn æxlum | |
| DK0818454T3 (da) | Benzimidazolderivater med antihistamin-aktivitet | |
| PT1117669E (pt) | Derivados de purina antivirais | |
| DE69804273D1 (de) | 5h-Thiazolo[3,2-a]pyrimidinderivate | |
| DE69720051D1 (de) | Harnstoffderivate | |
| FI960130A7 (fi) | Hepariinijohdannaiset, joilla on etäpesäkkeitä vastustava vaikutus | |
| FI970469L (fi) | Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus | |
| IS4791A (is) | 2-Amínó-5,6-díklóróbenzimídazól afleiður með virkni gegn veirum | |
| MXPA99001777A (es) | Dihidropirones con actividad antiviral mejorada. | |
| BR9707185A (pt) | Nucleosídeos de benzimidazol modificados como agentes antivirais | |
| FI953777A0 (fi) | Heteroaromaattisia yhdisteitä, joilla on antipsykoottinen aktiivisuus | |
| KR970703765A (ko) | 약리학적 활성을 갖는 2- 메르캅토벤조이미다졸 유도체(2-mercaptobenzimidazole derivatives possessing the pharmacological activity) | |
| FI951996A7 (fi) | 4-kinolinyylijohdannaiset, joilla on Helicobakteerin vastaista aktiivisuutta | |
| FI963222L (fi) | 6-substituoitu 4-amino-mykofenolihappo ja sen johdannaiset, joilla on immunosuppressiivista aktiivisuutta | |
| DE69929354D1 (de) | 2,4-disubstierte triazinderivate mit anti-hiv aktivität | |
| AU7040798A (en) | Pyrimidinone-1,3-oxathiolane derivatives with antiviral activity | |
| NO20000183L (no) | 5-substituerte-3-oksadiazolyl-1,6-naftyridin-2(1H)-on- derivater | |
| NO970498D0 (no) | Benzimidazolderivater med dopaminergisk aktivitet | |
| FI963073L (fi) | Makrosykliset difluorisatonijohdannaiset, jotka ovat käyttökelpoisia viruksia vastustavina aineina | |
| IT1286509B1 (it) | Derivati 2, 3, 4, 7-tetraidropiridoindazolo-(1,4)benzodiazepinici aventi attivita' antitumorale | |
| ZA979777B (en) | Dihydropyrones with improved antiviral activity. |